• Study of Mogamulizumab and Total Skin Electron Beam Therapy for Patients with Stage IB-IIB Cutaneous T-Cell Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Denmark France Germany Greece Italy Spain
  • Study of ALX148 and Pembrolizumab for Patients with Advanced Head and Neck Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Belgium The Netherlands Spain
  • Study on the Effects of Dirocaftor, Posenacaftor, and Nesolicaftor for Adults with Cystic Fibrosis

    Not recruiting

    2 1
    Investigated Diseases:
    Belgium Czechia France Germany Italy The Netherlands +3
  • Study on the Effects of Atidarsagene Autotemcel for Patients with Late Juvenile Metachromatic Leukodystrophy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy
  • Study on Isatuximab, Carfilzomib, and Dexamethasone for Adults with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    2 1 1 1
    Czechia Greece Portugal
  • Long-term safety study of garadacimab (CSL312) for prevention of hereditary angioedema attacks

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Germany Hungary The Netherlands Spain
  • Study on Reducing Protein in Urine for Patients with Chronic Kidney Disease Using Finerenone and Semaglutide

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Italy The Netherlands Spain
  • Study of Pembrolizumab with Chemotherapy for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

    Not recruiting

    3 1 1
    Czechia Denmark France Germany Ireland Italy +2
  • Study on Tirofiban and Aspirin for Patients with Acute Ischemic Stroke Due to Tandem Lesion

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Spain
  • Study on the Effectiveness and Safety of L19TNF and Dacarbazine for Patients with Advanced or Metastatic Soft-Tissue Sarcoma After Previous Treatments

    Not recruiting

    2 1 1 1
    France Germany Italy Poland Spain

powered by